11 results on '"Corso MD"'
Search Results
2. The Impact of 2020 and the Future of Cardiology Training
- Author
-
Prasanti Alekhya Kotta, MBChB, Brittany Corso, MD, Yevgeniy Brailovsky, DO, MSc, and Estefania Oliveros, MD, MSc
- Subjects
cardiovascular training ,education ,fellowship ,simulation ,telemedicine ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Published
- 2021
- Full Text
- View/download PDF
3. Use of a new face shield for patients of the endoscopy unit to avoid aerosol exchange in the COVID-19 era
- Author
-
Diego Mauricio Aponte Martín, MD, FASGE, Claudia Corso, MD, Carlos Fuentes, MD, Maria Valentina Aponte Aparicio, MST, and Luis Carlos Sabbagh, MD, FASGE
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Published
- 2020
- Full Text
- View/download PDF
4. COVID-19 in patients with psoriasis: A Latin American case series
- Author
-
Isabela Campo-Slebi, MD, María Fernanda Meza-Corso, MD, Paola Cárdenas, MD, Juan Raúl Castro-Ayarza, MD, Cesar González, MD, Carolina Cortés, MD, Manuel Franco, MD, and Fernando Valenzuela, MD
- Subjects
biologics ,COVID-19 ,psoriasis ,SARS-CoV-2 ,Dermatology ,RL1-803 - Published
- 2021
- Full Text
- View/download PDF
5. The Association Between Radiation Therapy Dose and Overall Survival in Patients With Intracranial Infiltrative Low-Grade Glioma Treated With Concurrent and/or Adjuvant Chemotherapy
- Author
-
Roshan S. Prabhu, MD, MS, Matthew C. Ward, MD, John H. Heinzerling, MD, Christopher D. Corso, MD, PhD, Zachary S. Buchwald, MD, PhD, Reshika Dhakal, MD, Anthony L. Asher, MD, Ashley L. Sumrall, MD, and Stuart H. Burri, MD
- Subjects
Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Purpose: Previous trials have shown no benefit for radiation therapy (RT) dose escalation when RT is given as adjuvant monotherapy for infiltrative low-grade glioma (LGG). However, the current standard of care for high-risk LGG is RT with concurrent and/or adjuvant chemotherapy. The effect of RT dose escalation on overall survival (OS) in the setting of concurrent and/or adjuvant chemotherapy is not well established. Methods and Materials: We used the National Cancer Database to select records for adult patients with intracranial grade 2 LGG diagnosed between 2004 and 2015. Patients must have received adjuvant external beam RT with concurrent and/or adjuvant chemotherapy. RT dose level was categorized as standard (45-54 Gy) or high (>54-65 Gy). Multivariable and propensity score matched analyses were used. Results: The study cohort consisted of 1043 patients, of whom 644 (62%) received standard dose (median, 54 Gy) and 399 (38%) received high-dose RT (median, 60 Gy). RT dose level was not associated with OS (hazard ratio, 1.2; P = .1) in multivariable analysis. Propensity score matching yielded 380 matched pairs (n = 760). There was no difference in OS for high-dose versus standard-dose RT in the matched cohort (5-year OS 64% vs 69%; P = .14) or in the 2 prespecified subgroups of astrocytoma histology and 1p/19q noncodeleted. Conclusions: Adjuvant RT dose escalation above 54 Gy in the setting of concurrent and/or adjuvant chemotherapy was not associated with improved OS for patients with infiltrative LGG in this National Cancer Database retrospective study. This was also true for the subgroups with less chemotherapy-sensitive disease, including astrocytoma histology and 1p/19q noncodeleted, although these analyses were limited by small size. Methods to improve OS other than RT dose escalation in the setting of concurrent and/or adjuvant chemotherapy should be considered for patients with poor-prognosis LGG.
- Published
- 2021
- Full Text
- View/download PDF
6. Aneurisma verdadero de la arteria femoral. Reporte de caso
- Author
-
Julián Moreno, MD and Claudia Corso, MD
- Subjects
vasos ,aneurismas ,enfermedad vascular periférica ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Los aneurismas verdaderos de la arteria femoral son un problema clínico infrecuente, y generalmente son publicados como reporte de caso en la literatura; su presentación puede ser variada, y aunque la mayoría son asintomáticos, pueden presentarse con cualquiera de sus complicaciones. Se expone el caso de un paciente de 85 años con aneurisma roto de la arteria femoral común izquierda, quien ingresa al servicio de urgencias y es intervenido quirúrgicamente de manera satisfactoria.
- Published
- 2013
- Full Text
- View/download PDF
7. Encefalopatía de Wernicke posterior a cirugía bariátrica: más que una pérdida de peso Wernicke encephalopathy following a bariatric surgery: more than weigth lossEncefalopatía de Wernicke posterior a cirugía bariátrica: más que una pérdida de peso; --- Wernicke encephalopathy following a bariatric surgery: more than weigth loss
- Author
-
Diana Lucía Franco Corso, MD, Tomás Carvajal, MD, Adriana Martínez Pérez, MD, and Iván Mauricio Peña, MD
- Subjects
Palabras clave: Encefalopatía de Wernicke ,Polineuropatía ,Cirugía bariátrica ,Tiamina ,Vitamina B1 ,Revisión de la Literatura. ,Key words Wernicke encephalophathy ,Polineuropathy ,Bariatric surgery ,Thiamine ,B1 vitamin ,Review. ,Medicine - Abstract
La encefalopatía de Wernicke y polineuropatía por deficiencia de tiamina (vitamina B1) es una de las posibles complicaciones neurológicas que comúnmente se presentan en pacientes sometidos a cirugías bariátricas. Al tener un aumento del número de procedimientos también se ha observado un aumento de estas complicaciones relacionadas a déficit vitamínico, y haciendo de esta condición relevante que debería conocerse por todos los profesionales de la salud; ya que su pronóstico está estrechamente relacionado con su prevención prequirúrgica y con la instauración rápida del tratamiento al tener una sospecha diagnóstica. La siguiente es una revisión de la literatura acerca de esta entidad; su presentación clínica, factores de riesgo, diagnóstico diferencial, tratamiento y pronóstico._____________________________________________________________________Wernicke encephalopathy and polyneuropathy related with Thiamine deficiency, is one of the possible neurologic complications that are commonly presented in patients who undergo bariatric surgery. With increasing number of bariatric procedures done there is also an increase in complications related to vitamin deficiency, making this arelevant condition that must be known by all healthcare professionals; mainly because its prognosis is closely related to its pre-surgical prevention and the prompt treatment when there is a clinical suspicious of the condition. The following in a literature review about this condition; its clinical presentation, risk factors, differential diagnosis, treatment and prognosis.
- Published
- 2011
8. Growth-promoting action and growth factor release by different platelet derivatives
- Author
-
Vittoria D'Esposito, Rossella Valentino, M Tia, Domenico Liguoro, Francesco Beguinot, Gilberto Sammartino, M Del Corso, M De Pascale, R Sepulveres, Pietro Formisano, Federica Passaretti, Passaretti, F, Tia, M, D'Esposito, V, Pascale, Md, Corso, Md, Sepulveres, R, Liguoro, D, Valentino, R, Beguinot, F, Formisano, P, and Sammartino, Gilberto
- Subjects
Adult ,Blood Platelets ,Male ,medicine.medical_specialty ,medicine.medical_treatment ,Biology ,chemistry.chemical_compound ,Young Adult ,Platelet degranulation ,Internal medicine ,medicine ,Human Umbilical Vein Endothelial Cells ,Humans ,Platelet ,Cell Proliferation ,Platelet-Rich Plasma ,Growth factor ,Hematology ,General Medicine ,Fibroblasts ,digestive system diseases ,Vascular endothelial growth factor ,Endocrinology ,chemistry ,Platelet-rich plasma ,biology.protein ,Cytokines ,Intercellular Signaling Peptides and Proteins ,Female ,Wound healing ,Platelet-derived growth factor receptor ,Transforming growth factor - Abstract
Platelet derivatives are commonly used in wound healing and tissue regeneration. Different procedures of platelet preparation may differentially affect growth factor release and cell growth. Preparation of platelet-rich fibrin (PRF) is accompanied by release of growth factors, including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF) and transforming growth factor ?1 (TGF?1), and several cytokines. When compared with the standard procedure for platelet-rich plasma (PRP), PRF released 2-fold less PDGF, but >15-fold and >2-fold VEGF and TGF?1, respectively. Also, the release of several cytokines (IL-4, IL-6, IL-8, IL-10, IFN?, MIP-1?, MIP-1? and TNF?) was significantly increased in PRF-conditioned medium (CM), compared to PRP-CM. Incubation of both human skin fibroblasts and human umbilical vein endothelial cells (HUVECs) with PRF-derived membrane (mPRF) or with PRF-CM enhanced cell proliferation by >2-fold (p < 0.05). Interestingly, PRP elicited fibroblast growth at a higher extent compared to PRF. At variance, PRF effect on HUVEC growth was significantly greater than that of PRP, consistent with a higher concentration of VEGF in the PRF-CM. Thus, the procedure of PRP preparation leads to a larger release of PDGF, as a possible result of platelet degranulation, while PRF enhances the release of proangiogenic factors.
- Published
- 2013
9. Excitation-contraction coupling inhibitors potentiate the actions of botulinum neurotoxin type A at the neuromuscular junction.
- Author
-
Machicoane M, Tonellato M, Zainotto M, Onillon P, Stazi M, Corso MD, Megighian A, Rossetto O, Le Doussal JM, and Pirazzini M
- Abstract
Background and Purpose: Botulinum neurotoxin type A1 (BoNT/A) is one of the most potent neurotoxins known. At the same time, it is also one of the safest therapeutic agents used for the treatment of several human disorders and in aesthetic medicine. Notwithstanding great effectiveness, strategies to accelerate the onset and prolong BoNT/A action would significantly ameliorate its pharmacological effects with beneficial outcomes for clinical use., Experimental Approach: Here, we combined BoNT/A with two fast-acting inhibitors of excitation-contraction coupling inhibitors (ECCI), either the μ-conotoxin CnIIIC or dantrolene, and tested the effect of their co-injection on a model of hind-limb paralysis in rodents using behavioural, biochemical, imaging and electrophysiological assays., Key Results: The BoNT/A-ECCI combinations accelerated the onset of muscle relaxation. Surprisingly, they also potentiated the peak effect and extended the duration of the three BoNT/A commercial preparations OnabotulinumtoxinA, AbobotulinumtoxinA and IncobotulinumtoxinA. ECCI co-injection increased the number of BoNT/A molecules entering motoneuron terminals, which induced a faster and greater cleavage of SNAP-25 during the onset and peak phases, and prolonged the attenuation of nerve-muscle neurotransmission during the recovery phase. We estimate that ECCI co-injection yields a threefold potentiation in BoNT/A pharmacological activity., Conclusions and Implications: Overall, our results show that the pharmacological activity of BoNT/A can be combined and synergized with other bioactive molecules and uncover a novel strategy to enhance the neuromuscular effects of BoNT/A without altering the neurotoxin moiety or intrinsic activity, thus maintaining its exceptional safety profile., (© 2024 The Author(s). British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.)
- Published
- 2024
- Full Text
- View/download PDF
10. New AMS 14 C dates track the arrival and spread of broomcorn millet cultivation and agricultural change in prehistoric Europe.
- Author
-
Filipović D, Meadows J, Corso MD, Kirleis W, Alsleben A, Akeret Ö, Bittmann F, Bosi G, Ciută B, Dreslerová D, Effenberger H, Gyulai F, Heiss AG, Hellmund M, Jahns S, Jakobitsch T, Kapcia M, Klooß S, Kohler-Schneider M, Kroll H, Makarowicz P, Marinova E, Märkle T, Medović A, Mercuri AM, Mueller-Bieniek A, Nisbet R, Pashkevich G, Perego R, Pokorný P, Pospieszny Ł, Przybyła M, Reed K, Rennwanz J, Stika HP, Stobbe A, Tolar T, Wasylikowa K, Wiethold J, and Zerl T
- Subjects
- Archaeology, Crops, Agricultural growth & development, Domestication, Europe, History, Ancient, Radiometric Dating, Agriculture history, Crops, Agricultural history, Panicum growth & development
- Abstract
Broomcorn millet (Panicum miliaceum L.) is not one of the founder crops domesticated in Southwest Asia in the early Holocene, but was domesticated in northeast China by 6000 BC. In Europe, millet was reported in Early Neolithic contexts formed by 6000 BC, but recent radiocarbon dating of a dozen 'early' grains cast doubt on these claims. Archaeobotanical evidence reveals that millet was common in Europe from the 2nd millennium BC, when major societal and economic transformations took place in the Bronze Age. We conducted an extensive programme of AMS-dating of charred broomcorn millet grains from 75 prehistoric sites in Europe. Our Bayesian model reveals that millet cultivation began in Europe at the earliest during the sixteenth century BC, and spread rapidly during the fifteenth/fourteenth centuries BC. Broomcorn millet succeeds in exceptionally wide range of growing conditions and completes its lifecycle in less than three summer months. Offering an additional harvest and thus surplus food/fodder, it likely was a transformative innovation in European prehistoric agriculture previously based mainly on (winter) cropping of wheat and barley. We provide a new, high-resolution chronological framework for this key agricultural development that likely contributed to far-reaching changes in lifestyle in late 2nd millennium BC Europe.
- Published
- 2020
- Full Text
- View/download PDF
11. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
- Author
-
Dohan Ehrenfest DM, Pinto NR, Pereda A, Jiménez P, Corso MD, Kang BS, Nally M, Lanata N, Wang HL, and Quirynen M
- Subjects
- Humans, Cells metabolism, Centrifugation methods, Fibrin metabolism, Intercellular Signaling Peptides and Proteins metabolism, Leukocytes metabolism, Platelet-Rich Fibrin metabolism
- Abstract
L-PRF (leukocyte- and platelet-rich fibrin) is one of the four families of platelet concentrates for surgical use and is widely used in oral and maxillofacial regenerative therapies. The first objective of this article was to evaluate the mechanical vibrations appearing during centrifugation in four models of commercially available table-top centrifuges used to produce L-PRF and the impact of the centrifuge characteristics on the cell and fibrin architecture of a L-PRF clot and membrane. The second objective of this article was to evaluate how changing some parameters of the L-PRF protocol may influence its biological signature, independently from the characteristics of the centrifuge. In the first part, four different commercially available centrifuges were used to produce L-PRF, following the original L-PRF production method (glass-coated plastic tubes, 400 g force, 12 minutes). The tested systems were the original L-PRF centrifuge (Intra-Spin, Intra-Lock, the only CE and FDA cleared system for the preparation of L-PRF) and three other laboratory centrifuges (not CE/FDA cleared for L-PRF): A-PRF 12 (Advanced PRF, Process), LW-UPD8 (LW Scientific) and Salvin 1310 (Salvin Dental). Each centrifuge was opened for inspection, two accelerometers were installed (one radial, one vertical), and data were collected with a spectrum analyzer in two configurations (full-load or half load). All clots and membranes were collected into a sterile surgical box (Xpression kit, Intra-Lock). The exact macroscopic (weights, sizes) and microscopic (photonic and scanning electron microscopy SEM) characteristics of the L-PRF produced with these four different machines were evaluated. In the second part, venous blood was taken in two groups, respectively, Intra-Spin 9 ml glass-coated plastic tubes (Intra-Lock) and A-PRF 10 ml glass tubes (Process). Tubes were immediately centrifuged at 2700 rpm (around 400 g) during 12 minutes to produce L-PRF or at 1500 rpm during 14 minutes to produce A-PRF. All centrifugations were done using the original L-PRF centrifuge (Intra-Spin), as recommended by the two manufacturers. Half of the membranes were placed individually in culture media and transferred in a new tube at seven experimental times (up to 7 days). The releases of transforming growth factor β-1 (TGFβ-1), platelet derived growth factor AB (PDGF-AB), vascular endothelial growth factor (VEGF) and bone morphogenetic protein 2 (BMP-2) were quantified using ELISA kits at these seven experimental times. The remaining membranes were used to evaluate the initial quantity of growth factors of the L-PRF and A-PRF membranes, through forcible extraction. Very significant differences in the level of vibrations at each rotational speed were observed between the four tested centrifuges. The original L-PRF centrifuge (Intra-Spin) was by far the most stable machine in all configurations and always remained under the threshold of resonance, unlike the three other tested machines. At the classical speed of production of L-PRF, the level of undesirable vibrations on the original centrifuge was between 4.5 and 6 times lower than with other centrifuges. Intra-Spin showed the lowest temperature of the tubes. A-PRF and Salvin were both associated with a significant increase in temperature in the tube. Intra-Spin produced the heaviest clot and quantity of exudate among the four techniques. A-PRF and LW produced much lighter, shorter and narrower clots and membranes than the two other centrifuges. Light microscopy analysis showed relatively similar features for all L-PRF types (concentration of cell bodies in the first half). However, SEM illustrated considerable differences between samples. The original Intra-Spin L-PRF showed a strongly polymerized thick fibrin matrix and all cells appeared alive with a normal shape, including the textured surface aspect of activated lymphocytes. The A-PRF, Salvin and LW PRF-like membranes presented a lightly polymerized slim fibrin gel and most of the visible cell bodies appeared destroyed (squashed or shrunk). In the second part of this study, the slow release of the three tested growth factors from original L-PRF membranes was significantly stronger (more than twice stronger, p<0.001) at all experimental times than the release from A-PRF membranes. No trace of BMP2 could be detected in the A-PRF. A slow release of BMP2 was detected during at least 7 days in the original L-PRF. Moreover, the original L-PRF clots and membranes (produced with 9 mL blood) were always significantly larger than the A-PRF (produced with 10 mL blood). The A-PRF membranes dissolved in vitro after less than 3 days, while the L-PRF membrane remained in good shape during at least 7 days. Each centrifuge has its clear own profile of vibrations depending on the rotational speed, and the centrifuge characteristics are directly impacting the architecture and cell content of a L-PRF clot. This result may reveal a considerable flaw in all the PRP/PRF literature, as this parameter was never considered. The original L-PRF clot (Intra-Spin) presented very specific characteristics, which appeared distorted when using centrifuges with a higher vibration level. A-PRF, LW and Salvin centrifuges produced PRF-like materials with a damaged and almost destroyed cell population through the standard protocol, and it is therefore impossible to classify these products in the L-PRF family. Moreover, when using the same centrifuge, the original L-PRF protocol allowed producing larger clots/membranes and a more intense release of growth factors (biological signature at least twice stronger) than the modified A-PRF protocol. Both protocols are therefore significantly different, and the clinical and experimental results from the original L-PRF shall not be extrapolated to the A-PRF. Finally, the comparison between the total released amounts and the initial content of the membrane (after forcible extraction) highlighted that the leukocytes living in the fibrin matrix are involved in the production of significant amounts of growth factors. The centrifuge characteristics and centrifugation protocols impact significantly and dramatically the cells, growth factors and fibrin architecture of L-PRF.
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.